Osmind study finds IV ketamine more effective than nasal esketamine for depression

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. IBM
2. PRIM
3. META
4. ABBV
5. NAVN
6. CNC
7. KFY
8. SPY
9. MU
10. DPZ

Go back to Osmind study finds IV ketamine more effective than nasal esketamine for depression
(NASDAQ: NRXP) Delayed: 3.90 --0 (-0%)
Previous Close $3.90    52 Week High $ 
Open $3.90    52 Week Low $ 
Day High $3.90    P/E N/A 
Day Low $3.90    EPS $ 
Volume 19,243